Loading AI tools
American geneticist From Wikipedia, the free encyclopedia
Moshe Szyf is a geneticist and James McGill professor of pharmacology and therapeutics at the McGill University, where he also holds a GlaxoSmithKline-CIHR chair in pharmacology.
Moshe Szyf | |
---|---|
Scientific career | |
Fields | Epigenetics and Cancer research |
Szyf's main research interests lie with epigenetics, including behavioral epigenetics as well as cancer research.
Szyf received his Ph.D. from the Hebrew University on basic mechanisms of DNA methylation under the supervision of Aharon Razin. Subsequently, he performed postdoctoral work at Harvard Medical School. In 1989, he was appointed as assistant professor in the department of Pharmacology and Therapeutics at McGill University in Montreal, Canada.[1] In 2016, Moshe Szyf founded Montreal EpiTerapia Inc. in Canada and HKG Epitherapeutics in Hong Kong in order to develop novel tools for the early detection of cancer and promoting healthy aging.
As of April 2019[update], Moshe Szyf published 295 papers in peer-reviewed journals, almost all on epigenetics[2] with a focus on cancer until the early 2000s and mostly environmental factors thereafter. He is a member of the editorial board of the journal Environmental Epigenetics, published by Oxford University Press.[3]
Szyf also holds many patents, all relating to epigenetics-based therapeutics.[4]
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.